Risk for Atherosclerotic CVD Up in Association With Cutaneous Lupus Erythematosus

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 16, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 15, 2025 -- Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD), similar to the risk seen in association with systemic lupus erythematosus (SLE), according to a study published online Dec. 4 in JAMA Dermatology.

Henry W. Chen, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined the incidence and prevalence of ASCVD among individuals with CLE, SLE, and psoriasis versus a disease-free control group in a retrospective longitudinal cohort study. The study included 8,138 persons with CLE, 24,675 with SLE, 192,577 with psoriasis, and 81,380 controls.

The researchers found that the odds of ASCVD were higher for patients with CLE and SLE than controls (odds ratios, 1.72 and 2.41, respectively), but not for those with psoriasis, in a multivariable analysis. Incidence rates of ASCVD were highest for individuals with SLE, followed by CLE, psoriasis, and controls at a median follow-up of three years (24.8, 15.2, 14.0, and 10.3 per 1,000 person-years, respectively). The highest risk for incident ASCVD was in those with SLE followed by CLE in multivariable Cox proportional regression modeling with the control groups as a reference group (hazard ratios, 2.23 and 1.32, respectively); the risk in those with psoriasis was not significantly increased.

"Clinicians caring for persons with CLE can counsel patients regarding the importance of a heart-healthy lifestyle including diet, exercise, and smoking avoidance," the authors write. "Regular monitoring of blood pressure and cholesterol and prompt treatment can also be recommended in this population."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-16 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords